Porphyrin and phthalocyanine antiviral compositions
US5281616A · kind A · utility
35Cited by
8References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 1992 |
| Grant date | Jan 25, 1994 |
| Priority date | — |
| Expiry date | Apr 24, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for the inhibition of replication of human immunodeficiency virus containing one or more "porphyrins" possessing antiviral activity. As used herein "porphyrins" includes porphyrins, phthalocyanines, chlorins, metallo derivatives thereof, and other porphyrin-like compounds. Examples of natural and synthetic, positively, negatively, and neutrally charged porphyrins, phthalocyanines, and derivatives thereof have been found to exhibit selective anti-HIV activity which is not dependent on the presence of light.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.